WASHINGTON — As legislation to address the opioid epidemic gains momentum, drug makers, insurers, and other interest groups are engaging in a concerted drive to tailor the bills to their liking.

The effort, in some cases, has resulted in lawmakers softening, or entirely backing off, some of their most far-reaching proposals.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Too bad they’re all so busy STILL trying to push Big Pharma drugs to get rich instead of help people. They neglect to even mention the most effective and the least expensive Opiate treatment available. It’s been on the market since the 1930’s and is hundreds of dollars less per month than ANY other drug that they feel is better. For years Insurance companies denied payment for it saying that there was no ‘scientific evidence it worked’. (Sound familiar) The fact is, no one gets fat rich off a drug that’s lost it’s patient long ago and is a cheep drug that happens to work so well they don’t even want people to know about it. They do not even mention it…why, it’s known as the “Gold Standard Treatment for Opiate Addiction” So many of our politicians hold stock in these treatment drug companies so if they hold back on a cheap drug/treatment, that leaves only the one they get rich on for you to purchase.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy